Literature DB >> 6886524

Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.

C S Wilcox, W E Mitch, R A Kelly, K Skorecki, T W Meyer, P A Friedman, P F Souney.   

Abstract

We investigated the effects of varying salt intake on five factors that could affect sodium balance during furosemide (F) administration: the quantity of F reaching the renal tubules; the magnitude of the acute natriuresis; Na+ excretion in the period after the acute diuresis; diuretic tolerance; and changes in plasma aldosterone. Six normal subjects were given F (40 mg day-1) for 3 days after equilibration to Na+ intakes of 20 mmol day-1 (low salt, LS) and 270 mmol day-1 (high salt, HS). Salt intake did not modify F excretion. Salt restriction reduced the short-term natriuretic response to F, led to diuretic tolerance, and potentiated the F-induced rise in plasma aldosterone. There was a progressive diminution in the quantity of Na+ excreted per unit of F excreted during LS. In spite of this, cumulative Na+ balance was negative only during LS because of a compensatory increase in Na+ reabsorption in the period between diuretic doses. During HS, this compensation exactly matched the short-term loss of Na+ produced by F, leading to neutral Na+ balance. During LS, the acute natriuresis exceeded the daily Na+ intake, so that, despite the renal compensation, Na+ balance was negative. In conclusion, salt restriction impairs the short-term natriuretic response to F and leads to diuretic tolerance. However, homeostatic mechanisms activated by the diuretic can maintain Na+ balance even in subjects without a disease causing Na+ retention, unless dietary salt is restricted.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886524

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  53 in total

1.  The influence of frusemide formulation on diuretic effect and efficiency.

Authors:  M Wakelkamp; A Blechert; M Eriksson; K Gjellan; C Graffner
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

Review 2.  Diuretics as a basis of antihypertensive therapy. An overview.

Authors:  N M Kaplan
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 3.  [Modern differential therapy with diuretics].

Authors:  D Fliser; H Haller
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

Review 4.  Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.

Authors:  H Knauf; E Mutschler
Journal:  Klin Wochenschr       Date:  1991-04-04

5.  Optimal use of diuretics in patients with heart failure.

Authors:  Jigar Patel; Michael Smith; J Thomas Heywood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

6.  The influence of drug input rate on the development of tolerance to frusemide.

Authors:  M Wakelkamp; G Alván; H Scheinin; J Gabrielsson
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

7.  Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure.

Authors:  Veena S Rao; Noah Planavsky; Jennifer S Hanberg; Tariq Ahmad; Meredith A Brisco-Bacik; Francis P Wilson; Daniel Jacoby; Michael Chen; W H Wilson Tang; David Z I Cherney; David H Ellison; Jeffrey M Testani
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

8.  Active sodium-urea counter-transport is inducible in the basolateral membrane of rat renal initial inner medullary collecting ducts.

Authors:  A Kato; J M Sands
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 9.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

10.  Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.

Authors:  João Pedro Ferreira; Nicolas Girerd; Pedro Bettencourt Medeiros; Mário Santos; Henrique Cyrne Carvalho; Paulo Bettencourt; David Kénizou; Javed Butler; Faiez Zannad; Patrick Rossignol
Journal:  Clin Res Cardiol       Date:  2015-11-28       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.